Blog

Georges Gebrael: Baseline bone pain associated with lower survival in mHSPC

Photo from Georges Gebrael/X

Jul 14, 2024, 06:27

Georges Gebrael: Baseline bone pain associated with lower survival in mHSPC

Georges Gebrael, Research Fellow at Huntsman Cancer Institute and University of Utah, shared on X/Twitter:

”Just in JAMA Network Open. Baseline bone pain associated with lower survival in mHSPC prostate cancer (patients level analysis of a SWOG Cancer Research Network ph3 trial). mHSPC patients with bone pain may be prioritized for trials.”

Bone Pain and Survival Among Patients With Metastatic, Hormone-Sensitive Prostate Cancer (A Secondary Analysis of the SWOG-1216 Trial)

Authors: Georges Gebrael, Yeonjung Jo, Umang Swami, Melissa Plets, Chadi Hage Chehade, Arshit Narang, Shilpa Gupta, Zin W. Myint, Nicolas Sayegh, Catherine M. Tangen, Maha Hussain, Tanya Dorff, Primo N. Lara Jr, Seth P. Lerner, Ian Thompson, Neeraj Agarwal.

Georges Gebrael

Source: Georges Gebrael/X

Arshit Narang cancer Cancer research cancer trial Catherine M. Tangen Chadi Hage Chehade Georges Gebrael Huntsman Cancer Institute Ian Thompson JAMA Network Open Maha Hussain Melissa Plets Neeraj Agarwal Nicolas Sayegh OncoDaily Oncology Primo N Lara Jr prostate cancer Seth P. Lerner Shilpa Gupta SWOG Cancer Research Network Tanya Dorff Umang Swami University of Utah Yeonjung Jo Zin W. Myint

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage